Home
About
Overview
Management Team
Board of Directors
Clinical Advisors
SYN-004 Phase 3 Steering Committee
Careers
Product Pipeline
Overview
SYN-004 (ribaxamase)
SYN-004 Phase 3 Steering Committee
SYN-010
News & Media
Overview
Press Releases
Events
In the News
Scientific Publications
Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact
All SEC Filings
Menu
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Information
Profile
Presentations
Management Team
Contacts
Analyst Coverage
FAQ
Financial Information
Financials
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Quick Links
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Filter Filings:
View All
10-K
10-K/A
10-K405
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
3
4
4/A
424B2
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
AW
CERTAMX
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
EFFECT
FWP
NT 10-K
POS AM
POS EX
PRE 14A
PRE 14C
PRER14A
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
05/07/96
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
23
<< Previous
1...
62
63
64
65
66
67
68
69
70
71
